XML 52 R36.htm IDEA: XBRL DOCUMENT
v3.24.1

Shareholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Shareholders' Equity [Abstract] |
Schedule of Outstanding Warrants to Shareholders | The Company’s outstanding warrants to shareholders as of December 31, 2023 are as follows:
Outstanding and exercisable warrants |  | Weighted average exercise price of outstanding warrants |  |  | Weighted average Remaining contractual life (years) |
1,553,933 |  |  | 2.80 |  |  |  | 2.35 |
Schedule of Employee and Director Stock Option Activity and Related Information | A summary of the Company’s employee and director stock option activity and related information for the year ended December 31, 2023, is as follows:
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | Number of options |  |  | Weighted- average exercise price |  |  | Number of options |  |  | Weighted average exercise price |  |  | Number of options |  |  | Weighted- average exercise price |
Outstanding - beginning of year |  |  | 347,333 |  |  | $ | 2.79 |  |  |  | 275,833 |  |  | $ | 2.40 |  |  |  | 170,500 |  |  | $ | 2.30 |
Changes during the year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted |  |  | - |  |  | $ | - |  |  |  | 87,500 |  |  | $ | 2.25 |  |  |  | 175,000 |  |  | $ | 3.36 |
Exercised |  |  | (46,500 | ) |  | $ | 2.16 |  |  |  | (1,000 | ) |  | $ | 2.12 |  |  |  | (52,167 | ) |  | $ | 2.29 |
Forfeited |  |  | - |  |  | $ | - |  |  |  | (15,000 | ) |  | $ | 2.80 |  |  |  | (17,500 | ) |  | $ | 2.44 |
Outstanding - year end |  |  | 300,833 |  |  | $ | 2.89 |  |  |  | 347,333 |  |  | $ | 2.79 |  |  |  | 275,833 |  |  | $ | 2.40 |
Vested and expected to vest |  |  | 183,333 |  |  | $ | 2.95 |  |  |  | 164,166 |  |  | $ | 2.61 |  |  |  | 83,334 |  |  | $ | 2.22 |
Exercisable at year end |  |  | 156,666 |  |  | $ | 3.09 |  |  |  | 136,499 |  |  | $ | 2.71 |  |  |  | 51,667 |  |  | $ | 2.26 |
Schedule of Options Granted to Employees and Directors | Options granted to employees and directors that are outstanding as of December 31, 2023 broken into exercise prices, are as follows:
|  |  |  |  |  |  |  |  |  |  | Weighted average |
|  | Options |  |  | Weighted |  |  | Options |  |  | Remaining |
|  | outstanding |  |  | average |  |  | exercisable |  |  | Contractual |
|  | as of |  |  | remaining |  |  | as of |  |  | life of options |
Exercise |  | December 31, |  |  | contractual |  |  | December 31, |  |  | exercisable |
Price |  | 2023 |  |  | life (years) |  |  | 2023 |  |  | (years) |
2.118 |  |  | 13,333 |  |  |  | 0.83 |  |  |  | 13,333 |  |  |  | 0.83 |
2.176 |  |  | 10,000 |  |  |  | 1.08 |  |  |  | 10,000 |  |  |  | 1.08 |
2.245 |  |  | 87,500 |  |  |  | 3.96 |  |  |  | - |  |  |  | 3.96 |
2.433 |  |  | 7,500 |  |  |  | 2.02 |  |  |  | 5,000 |  |  |  | 2.02 |
2.775 |  |  | 20,000 |  |  |  | 1.96 |  |  |  | 20,000 |  |  |  | 1.96 |
3.195 |  |  | 20,000 |  |  |  | 2.14 |  |  |  | 13,333 |  |  |  | 2.14 |
3.251 |  |  | 7,500 |  |  |  | 2.81 |  |  |  | 5,000 |  |  |  | 2.81 |
3.252 |  |  | 100,000 |  |  |  | 2.81 |  |  |  | 66,667 |  |  |  | 2.81 |
3.863 |  |  | 30,000 |  |  |  | 2.75 |  |  |  | 20,000 |  |  |  | 2.75 |
4.022 |  |  | 5,000 |  |  |  | 2.67 |  |  |  | 3,333 |  |  |  | 2.67 |
Grand Total |  |  | 300,833 |  |  |  | 2.87 |  |  |  | 156,666 |  |  |  | 2.33 |

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration